Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Clinical and Translational Science|May 13, 2021
Design and conduct considerations for studies in patients with impaired renal functionPaulien Ravenstijn, Manoranjenni Chetty, Pooja ManchandaniClinical Pharmacology and Therapeutics|September 24, 2020
Clopidogrel Dosing: Current Successes and Emerging Factors for Further ConsiderationManoranjenni Chetty, Paulien Ravenstijn, Pooja ManchandaniAntimicrobial Agents and Chemotherapy|October 5, 2016
Comparative Pharmacokinetic Profiling of Different Polymyxin B ComponentsPooja Manchandani, Yanina Dubrovskaya, Song Gao, et al.Clinical Pharmacology and Therapeutics|July 3, 2022
Trends in FDA Transporter-Based Post-Marketing Requirements and Commitments Over the Last DecadeIslam R Younis, Pooja Manchandani, Hazem E Hassan, et al.Journal of Advanced Pharmaceutical Technology & Research|January 17, 2012
Recent trends in the impurity profile of pharmaceuticalsKavita Pilaniya, Harish K Chandrawanshi, Urmila Pilaniya, et al.Clinical and Translational Science|September 30, 2022
Design and conduct considerations for studies in patients with hepatic impairmentPaulien Ravenstijn, Manoranjenni Chetty, Pooja Manchandani, et al.Pharmaceutics|November 25, 2023
PBPK Modeling of Azithromycin Systemic Exposure in a Roux-en-Y Gastric Bypass Surgery Patient PopulationSuvarchala Kiranmai Avvari, Jaclyn A Cusumano, Vamshi Krishna Jogiraju, et al.Antimicrobial Agents and Chemotherapy|November 2, 2016
Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal InsufficiencyVisanu Thamlikitkul, Yanina Dubrovskaya, Pooja Manchandani, et al.Clinical Pharmacology and Therapeutics|December 15, 2017
Population Pharmacokinetics of Polymyxin BPooja Manchandani, Visanu Thamlikitkul, Yanina Dubrovskaya, et al.Antimicrobial Agents and Chemotherapy|January 19, 2017
Role of Renal Drug Exposure in Polymyxin B-Induced NephrotoxicityPooja Manchandani, Jian Zhou, Jessica T Babic, et al.Pageof 2